BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Genetown

  Seaside Therapeutics Announces Issuance of Key Patent for Lead Autism Candidate STX209

  March 28, 2012

   · 

  1 min read
• Drug Development

  Amsterdam Molecular Therapeutics (AMT) Publishes Positive Data from Glybera® 14 Week Study

  March 28, 2012

   · 

  4 min read
• Drug Development

  Biota Holdings Limited Announces Positive Phase IIb Data for Asthmatic Patients With Human Rhinovirus Infection (HRV)

  March 28, 2012

   · 

  5 min read
• Business

  FDA Commissioner Hamburg ‘Must Go’ Says AHF

  March 28, 2012

   · 

  1 min read
• Business

  Pernix Therapeutics, Inc. Reports Fourth Quarter and Full Year 2011 Financial Results

  March 28, 2012

   · 

  1 min read
• Business

  Paratek Pharmaceuticals, Inc. Wins Agreement With FDA on Special Protocol Assessment (SPA) for Phase 3 Study in Community-Acquired Bacterial Pneumonia (CABP)

  March 28, 2012

   · 

  4 min read
• Drug Development

  iSonea Limited Announces Initiation of Pediatric Asthma Study

  March 28, 2012

   · 

  1 min read
• Pharm Country

  NPS Pharmaceuticals, Inc. to Present at Needham Healthcare Conference

  March 28, 2012

   · 

  1 min read
• Business

  Quintiles, Inc. to Quantify Healthcare Decisions Using Archimedes, Inc. Simulator

  March 28, 2012

   · 

  1 min read
• FDA

  Quidel Corporation Receives CE Mark for Its AmpliVue(TM) Hand-Held Molecular Diagnostic Test for Clostridium Difficile

  March 28, 2012

   · 

  5 min read